Sheila DeWitt
Vermogen: 17 912 $ op 31-05-2026
Vermogen: 17 912 $ op 31-05-2026
Sheila DeWitt is the founder of Deuterx LLC, founded in 2012, holding the titles of Chairman, President & Chief Executive Officer.
Dr. DeWitt is also the founder of Diversomer Technologies, Inc...
Dr. DeWitt currently serves as Director at Riffit, Inc., Chief Operating Officer & Director at Neuromity Therapeutics, Inc., and Independent Director at Enveric Biosciences, Inc. since 2024.
Former positions include Chairman, President & Chief Executive Officer at Deuteria Pharmaceuticals, Inc. from 2010 to 2012, Vice President-Portfolio Development at ArQule, Inc., Vice President-Discovery at EPIX Pharmaceuticals, Inc. from 2005 to 2009, and Business Unit Head at Orchid Cellmark, Inc. Education includes a doctorate from Duke University conferred in 1986 and an undergraduate degree from Cornell University conferred in 1982.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2026 | 7.788 ( 0,21% ) | 17 912 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Directeur/Bestuurslid | 01-05-2024 |
Deuterx LLC
Deuterx LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company provides drugs for patients | Algemeen Directeur | 01-01-2012 |
Riffit, Inc.
Riffit, Inc. Medical/Nursing ServicesHealth Services Provides musical therapy solutions | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Deuteria Pharmaceuticals, Inc.
Deuteria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Algemeen Directeur | 01-12-2012 |
Diversomer Technologies, Inc. | Oprichter | - |
| ARQULE, INC. | Corporate Officer/Principal | - |
Orchid Cellmark, Inc.
Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Corporate Officer/Principal | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
Orchid Cellmark, Inc.
Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Commercial Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Diversomer Technologies, Inc. | |
Deuterx LLC
Deuterx LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company provides drugs for patients | Health Technology |
Deuteria Pharmaceuticals, Inc.
Deuteria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Enveric Biosciences, Inc.
Enveric Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Health Technology |
Riffit, Inc.
Riffit, Inc. Medical/Nursing ServicesHealth Services Provides musical therapy solutions | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau